Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
19961.1k citationsMichael Hahne, Donata Rimoldi et al.Scienceprofile →
High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
1992571 citationsD Liénard, Patricia Ewalenko et al.Journal of Clinical Oncologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of D Liénard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Liénard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Liénard more than expected).
This network shows the impact of papers produced by D Liénard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Liénard. The network helps show where D Liénard may publish in the future.
Co-authorship network of co-authors of D Liénard
This figure shows the co-authorship network connecting the top 25 collaborators of D Liénard.
A scholar is included among the top collaborators of D Liénard based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with D Liénard. D Liénard is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Valmori, Danila, Mikäel J. Pittet, Cédric Vonarbourg, et al.. (1999). Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.. PubMed. 59(16). 4050–5.63 indexed citations
10.
Eggermont, A.M.M., et al.. (1997). Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas.. PubMed. 24(5). 547–55.28 indexed citations
11.
Valmori, Danila, D Liénard, Gary A. Waanders, et al.. (1997). Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.. PubMed. 57(4). 735–41.52 indexed citations
Hahne, Michael, Donata Rimoldi, Michael Schröter, et al.. (1996). Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape. Science. 274(5291). 1363–1366.1052 indexed citations breakdown →
14.
Lejeune, F., D Liénard, A.M.M. Eggermont, et al.. (1995). Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results.. PubMed. 5(2). 73–81.20 indexed citations
15.
Lejeune, F., D Liénard, A Eggermont, et al.. (1994). Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma.. PubMed. 43(4). 191–7.37 indexed citations
16.
Liénard, D, et al.. (1994). Physiological and pharmacokinetics parameters in isolation perfusion of the limbs.. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 241–248.2 indexed citations
Liénard, D, et al.. (1992). High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.. Journal of Clinical Oncology. 10(1). 52–60.571 indexed citations breakdown →
19.
Lejeune, Ferdinand, et al.. (1989). Assessment of the haematocrit method for dosimetry of cytostatics in isolation perfusion. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 2. 82–86.7 indexed citations
20.
Lejeune, Ferdinand, et al.. (1989). Results of 206 isolated limb perfusions for malignant melanoma.. PubMed. 15(6). 510–9.36 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.